TheBrief.Health
A novel smart device for heart failure decongestion uses pressure-guided fluid redistribution to reduce congestion, potentially improving symptoms, lowering hospitalizations, and enabling remote monitoring.
Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de TheBrief.Health!
$99 / mes después de la prueba. · Cancela cuando quieras.
500 episodios
THT 2026: First-In-Human Smart Implant—Heart Failure Decongestion
Sphingolipid to Steroid Ratio May Predict Asthma Exacerbations
Metabolomic profiling is emerging as a promising tool for predicting asthma exacerbations, enabling earlier risk identification, personalized treatment strategies, and potentially reducing hospitalizations through proactive disease management.
Early Promise of Flexible ECAP-Based Spinal Cord Stimulation for Chronic Pain Relief
ECAP-guided spinal cord stimulation enables real-time, adaptive pain management, offering more consistent symptom relief and reducing reliance on opioids for chronic pain patients.
Unlocking the Potential of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Weight Loss and Heart Health
Emerging obesity treatments may deliver both weight-loss and cardiovascular benefits, offering new options to reduce heart disease risk while addressing the growing obesity epidemic.
Current Status of Retinal Diagnostics In Alzheimer’s Disease
Retinal imaging may offer a noninvasive way to detect early Alzheimer’s-related brain changes, supporting earlier screening, risk assessment, and referral before significant cognitive decline occurs.
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de TheBrief.Health!